Changing heat and moisture exchangers every 48 hours rather than 24 hours does not affect their efficacy and the incidence of nosocomial pneumonia. 1995

K Djedaini, and M Billiard, and L Mier, and G Le Bourdelles, and P Brun, and P Markowicz, and P Estagnasie, and F Coste, and Y Boussougant, and D Dreyfuss
Service de Réanimation Médicale, Hôpital Louis Mourier, Colombes, France.

Heat and moisture exchangers (HME) (Dar-Hygrobac II, Peters) can safely be used every 24 h for long-term mechanical ventilation and provide a cost-saving alternative to heated humidifiers. We have prospectively determined whether changing HMEs every 48 h only affects their clinical and bacteriological efficiency in a series of consecutive nonselected ICU patients requiring long-term mechanical ventilation. Two consecutive periods were compared. During period 1, HMEs were replaced every day; during period 2, they were changed every 48 h. Patients from the two periods were similar in terms of age and indication for and overall duration of MV (10 +/- 8.6 versus 10 +/- 9 d, p = 0.9). Minute ventilation and maximum values for peak airway pressure were identical during the two periods. These values were also identical after 1 and 2 d of HME use during period 2, indicating that HME resistance was not increased by prolonged use. Obstruction of the tracheal tube occurred only once in a period 1 patient. The results of quantitative cultures indicate that the maximum and mean levels of bacterial colonization during the two periods were similar for the pharynx, trachea, Y-connector, patient, and ventilator side of the HME. More importantly, the incidence of nosocomial pneumonia was similar during the two periods (6/61 versus 8/68, p = 0.7). Thus, prolonged HME use is safe and provides a substantial reduction in the cost of mechanical ventilation.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012121 Respiration, Artificial Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2). Ventilation, Mechanical,Mechanical Ventilation,Artificial Respiration,Artificial Respirations,Mechanical Ventilations,Respirations, Artificial,Ventilations, Mechanical
D003362 Cost-Benefit Analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes. Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D004866 Equipment Contamination The presence of an infectious agent on instruments, prostheses, or other inanimate articles. Contamination, Equipment,Contaminations, Equipment,Equipment Contaminations
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Djedaini, and M Billiard, and L Mier, and G Le Bourdelles, and P Brun, and P Markowicz, and P Estagnasie, and F Coste, and Y Boussougant, and D Dreyfuss
March 1998, Critical care medicine,
K Djedaini, and M Billiard, and L Mier, and G Le Bourdelles, and P Brun, and P Markowicz, and P Estagnasie, and F Coste, and Y Boussougant, and D Dreyfuss
May 1999, Infection control and hospital epidemiology,
K Djedaini, and M Billiard, and L Mier, and G Le Bourdelles, and P Brun, and P Markowicz, and P Estagnasie, and F Coste, and Y Boussougant, and D Dreyfuss
March 2000, Critical care medicine,
K Djedaini, and M Billiard, and L Mier, and G Le Bourdelles, and P Brun, and P Markowicz, and P Estagnasie, and F Coste, and Y Boussougant, and D Dreyfuss
November 1999, Intensive care medicine,
K Djedaini, and M Billiard, and L Mier, and G Le Bourdelles, and P Brun, and P Markowicz, and P Estagnasie, and F Coste, and Y Boussougant, and D Dreyfuss
May 2000, Critical care medicine,
K Djedaini, and M Billiard, and L Mier, and G Le Bourdelles, and P Brun, and P Markowicz, and P Estagnasie, and F Coste, and Y Boussougant, and D Dreyfuss
September 2000, Infection control and hospital epidemiology,
K Djedaini, and M Billiard, and L Mier, and G Le Bourdelles, and P Brun, and P Markowicz, and P Estagnasie, and F Coste, and Y Boussougant, and D Dreyfuss
May 1999, Critical care medicine,
K Djedaini, and M Billiard, and L Mier, and G Le Bourdelles, and P Brun, and P Markowicz, and P Estagnasie, and F Coste, and Y Boussougant, and D Dreyfuss
March 1990, Critical care medicine,
K Djedaini, and M Billiard, and L Mier, and G Le Bourdelles, and P Brun, and P Markowicz, and P Estagnasie, and F Coste, and Y Boussougant, and D Dreyfuss
April 1995, American journal of respiratory and critical care medicine,
K Djedaini, and M Billiard, and L Mier, and G Le Bourdelles, and P Brun, and P Markowicz, and P Estagnasie, and F Coste, and Y Boussougant, and D Dreyfuss
November 1998, Chest,
Copied contents to your clipboard!